EntryPoint Capital LLC Buys Shares of 19,485 Tactile Systems Technology, Inc. (NASDAQ:TCMD)

EntryPoint Capital LLC bought a new position in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 19,485 shares of the company’s stock, valued at approximately $334,000. EntryPoint Capital LLC owned approximately 0.08% of Tactile Systems Technology as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in TCMD. Jones Financial Companies Lllp purchased a new stake in Tactile Systems Technology during the fourth quarter worth about $39,000. 1620 Investment Advisors Inc. acquired a new stake in shares of Tactile Systems Technology during the 4th quarter valued at approximately $97,000. AlphaQuest LLC purchased a new stake in shares of Tactile Systems Technology during the 4th quarter worth approximately $158,000. Retireful LLC acquired a new stake in shares of Tactile Systems Technology in the 4th quarter worth approximately $173,000. Finally, XTX Topco Ltd purchased a new position in Tactile Systems Technology in the 3rd quarter valued at approximately $163,000. 83.43% of the stock is owned by institutional investors and hedge funds.

Tactile Systems Technology Price Performance

TCMD stock opened at $13.38 on Thursday. The stock’s 50 day moving average price is $15.65 and its 200 day moving average price is $15.81. The firm has a market cap of $315.57 million, a P/E ratio of 19.11 and a beta of 1.24. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.80 and a current ratio of 4.36. Tactile Systems Technology, Inc. has a 1 year low of $11.12 and a 1 year high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.09. The business had revenue of $85.59 million for the quarter, compared to the consensus estimate of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. On average, sell-side analysts expect that Tactile Systems Technology, Inc. will post 0.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tactile Systems Technology news, Director Daniel L. Reuvers sold 10,938 shares of the business’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.55, for a total value of $159,147.90. Following the completion of the transaction, the director now directly owns 242,942 shares in the company, valued at approximately $3,534,806.10. The trade was a 4.31 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Kristie Burns sold 4,830 shares of the firm’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.65, for a total value of $70,759.50. Following the sale, the vice president now owns 84,008 shares in the company, valued at $1,230,717.20. This trade represents a 5.44 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 19,546 shares of company stock valued at $285,444 in the last ninety days. Insiders own 0.96% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on TCMD. StockNews.com raised Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a report on Friday, March 21st. B. Riley cut shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $23.00 to $18.00 in a research note on Wednesday, February 19th.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.